Exponent, Inc. (NASDAQ:EXPO – Get Free Report) VP Richard Reiss sold 1,736 shares of the firm’s stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the completion of the transaction, the vice president now directly owns 1,800 shares of the company’s stock, valued at $154,674. This represents a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Exponent Price Performance
EXPO stock traded down $0.07 during trading hours on Thursday, reaching $85.64. The stock had a trading volume of 36,222 shares, compared to its average volume of 232,591. The stock has a 50-day simple moving average of $90.01 and a 200 day simple moving average of $99.18. Exponent, Inc. has a fifty-two week low of $77.21 and a fifty-two week high of $115.75. The stock has a market capitalization of $4.35 billion, a PE ratio of 40.40 and a beta of 0.71.
Exponent (NASDAQ:EXPO – Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same quarter in the prior year, the firm earned $0.41 EPS. On average, sell-side analysts forecast that Exponent, Inc. will post 1.98 EPS for the current fiscal year.
Exponent Increases Dividend
Hedge Funds Weigh In On Exponent
Several institutional investors and hedge funds have recently modified their holdings of the stock. Castlekeep Investment Advisors LLC acquired a new stake in shares of Exponent during the 4th quarter worth about $413,000. US Asset Management LLC acquired a new stake in Exponent during the fourth quarter worth approximately $278,000. PharVision Advisers LLC acquired a new stake in Exponent during the fourth quarter worth approximately $226,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Exponent by 15.1% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 159,131 shares of the business services provider’s stock valued at $14,179,000 after purchasing an additional 20,904 shares during the last quarter. Finally, Squarepoint Ops LLC grew its position in shares of Exponent by 59.7% in the fourth quarter. Squarepoint Ops LLC now owns 46,950 shares of the business services provider’s stock valued at $4,183,000 after purchasing an additional 17,555 shares during the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories
- Five stocks we like better than Exponent
- What is the Australian Securities Exchange (ASX)
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Growth Stocks: What They Are, Examples and How to Invest
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Will Alibaba’s $53B AI Bet Be the Key to Tech Supremacy?
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.